Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: A proteomic approach

International Journal of Cardiology

Volumn 170, Issue 1, 2013, Pages 69-74

  Tasaki, Masayoshi ^a   Ueda, Mitsuharu ^a   Obayashi, Konen ^b   Koike, Haruki ^c   Kitagawa, Keisuke ^a   Ogi, Yasuhiro ^a   Jono, Hirofumi ^d   Su, Yu ^a   Suenaga, Genki ^a   Oshima, Toshinori ^a   Misumi, Yohei ^a   Yoshida, Mari ^e   Yamashita, Taro ^a   Sobue, Gen ^c   Ando, Yukio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Aging; Amyloidosis; Familial amyloidotic polyneuropathy; Proteome; Sex differences; Transthyretin

Indexed keywords

AMYLOID; PREALBUMIN;

ADULT; AGE; ARTICLE; AUTOPSY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEOMICS; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; WILD TYPE;

AGING; AMYLOIDOSIS; FAMILIAL AMYLOIDOTIC POLYNEUROPATHY; PROTEOME; SEX DIFFERENCES; TRANSTHYRETIN;

ADULT; AGE FACTORS; AMYLOID NEUROPATHIES, FAMILIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; PREALBUMIN; PROTEOMICS; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84887988397     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.033     Document Type: Article

References (25)

1. Y. Ando, M. Nakamura, and S. Araki Transthyretin-related familial amyloidotic polyneuropathy Arch Neurol 62 2005 1057 1062
2. Y. Ando, T. Coelho, and J.L. Berk Guideline of transthyretin-related hereditary amyloidosis for clinicians Orphanet J Rare Dis 8 2013 31
3. H. Koike, Y. Ando, and M. Ueda Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy J Neurol Sci 287 2009 178 184
4. A. Tsuchiya-Suzuki, M. Yazaki, F. Kametani, Y. Sekijima, and S. Ikeda Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met Hum Pathol 42 2011 236 243
5. L.H. Connors, A. Lim, T. Prokaeva, V.A. Roskens, and C.E. Costello Tabulation of human transthyretin (TTR) variants, 2003 Amyloid 10 2003 160 184
6. J.D. Sipe, M.D. Benson, and J.N. Buxbaum Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis Amyloid 19 2012 167 170
7. G. Holmgren, P.M. Costa, and C. Andersson Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate J Med Genet 31 1994 351 354
8. A. Sousa, T. Coelho, J. Barros, and J. Sequeiros Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal) Am J Med Genet 60 1995 515 521
9. V. Planté-Bordeneuve, A. Ferreira, and T. Lalu Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP) Neurology 69 2007 693 698
10. K. Misu, N. Hattori, and M. Nagamatsu Late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features Brain 122 1999 1951 1962
11. H. Koike, K. Misu, and S. Ikeda Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form Arch Neurol 59 2002 1771 1776
12. H. Koike, K. Misu, and M. Sugiura Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy Neurology 63 2004 129 138
13. H. Koike, Y. Kawagashira, and M. Iijima Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci J Neurol 255 2008 1526 1533
14. P. Westermark, K. Sletten, B. Johansson, and G.G. Cornwell III Fibril in senile systemic amyloidosis is derived from normal transthyretin Proc Natl Acad Sci U S A 87 1990 2843 2845
15. G.G. Cornwell III, K. Sletten, B. Johansson, and P. Westermark Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin Biochem Biophys Res Commun 154 1988 648 653
16. M. Ueda, Y. Horibata, and M. Shono Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study Mod Pathol 24 2011 1533 1544
17. C. Rapezzi, C.C. Quarta, and L. Riva Transthyretin-related amyloidoses and the heart: a clinical overview Nat Rev Cardiol 7 2010 398 408
18. J.A. Vrana, J.D. Gamez, B.J. Madden, J.D. Theis, H.R. Bergen 3rd, and A. Dogan Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens Blood 114 2009 4957 4959
19. H. Puchtler, F. Sweat, and M. Levine On the binding of Congo red by amyloid J Histochem Cytochem 10 1962 355 364
20. T. Bolmont, F. Clavaguera, and M. Meyer-Luehmann Induction of tau pathology by intracerebral infusion of amyloid-β-containing brain extract and by amyloid-β deposition in APP × Tau transgenic mice Am J Pathol 171 2007 2012 2020
21. O.B. Suhr, P. Lindqvist, B.O. Olofsson, A. Waldenström, and C. Backman Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy Amyloid 13 2006 154 159
22. C. Rapezzi, L. Riva, and C.C. Quarta Gender-related risk of myocardial involvement in systemic amyloidosis Amyloid 15 2008 40 48
23. R.A. Kyle, P.C. Spittell, and M.A. Gertz The premortem recognition of systemic senile amyloidosis with cardiac involvement Am J Med 101 1996 395 400
24. B. Ng, L.H. Connors, R. Davidoff, M. Skinner, and R.H. Falk Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis Arch Intern Med 165 2005 1425 1429
25. S. Okamoto, J. Wixner, and K. Obayashi Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients' survival Liver Transpl 15 2009 1229 1235